WO2025019403 - SUBSTITUTED AMINO-PHENYLMETHYLENE-IMIDAZOLONES
National phase entry is expected:
Publication Number
WO/2025/019403
Publication Date
23.01.2025
International Application No.
PCT/US2024/037994
International Filing Date
15.07.2024
Title **
[English]
SUBSTITUTED AMINO-PHENYLMETHYLENE-IMIDAZOLONES
[French]
AMINO-PHÉNYLMÉTHYLÈNE-IMIDAZOLONES SUBSTITUÉES
Applicants **
DWULET, Gregory
Inventors
DWULET, Gregory
Priority Data
63/527,013
15.07.2023
US
63/655,031
02.06.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
USPTO
* |
| * | |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Natural Person
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3708 | |
| EPO | Filing, Examination, Granting | 32506 | |
| Japan | Filing, Examination, Granting | 3640 | |
| South Korea | Filing, Examination, Granting | 5219 | |
| USA | Filing, Examination, Granting | 18110 |
Total:
63,183
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates in some aspects to novel compounds containing an amino-phenylmethylene-imidazolone (i.e., amino-phenylmethylidene-imidazolone) core structure. In some aspects, the disclosure further relates to methods of synthesizing the compounds, compositions containing the compounds, and methods of using such compounds, including their administration to subjects. In aspects, features of the compounds include neuromodulatory activity, for example, antagonism of serotonin receptors. In some aspects, the compounds are useful as therapeutic agents, e.g., antipsychotic agents[French]
La présente divulgation concerne, selon certains aspects, de nouveaux composés contenant une structure centrale d'amino-phénylméthylène-imidazolone (c'est-à-dire, amino-phénylméthylidène-imidazolone). Selon certains aspects, la divulgation concerne en outre des procédés de synthèse des composés, des compositions contenant les composés, et des procédés d'utilisation de tels composés, y compris leur administration à des sujets. Dans certains aspects, des caractéristiques des composés comprennent une activité neuromodulatrice, par exemple, un antagonisme de récepteurs de la sérotonine. Dans certains aspects, les composés sont utiles en tant qu'agents thérapeutiques, par exemple, en tant qu'agents antipsychotiques.